BioStem Technologies, Inc.
BSEM
$5.80
-$0.16-2.69%
OTC PK
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 206.35% | 215.82% | 147.76% |
| Total Depreciation and Amortization | -- | -- | 10.60% | 27.19% | 5.84% |
| Total Amortization of Deferred Charges | -- | -- | 641.26% | 867.19% | -- |
| Total Other Non-Cash Items | -- | -- | -14.02% | -52.79% | 6.73% |
| Change in Net Operating Assets | -- | -- | -3,078.77% | -1,941.25% | -1,142.26% |
| Cash from Operations | -- | -- | 691.61% | 693.43% | 308.56% |
| Capital Expenditure | -- | -- | -97.59% | -99.73% | -298.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 53.52% | 53.52% | 53.52% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -1,310.36% | -1,310.36% | 123.88% |
| Cash from Investing | -- | -- | -450.48% | -451.62% | -9.99% |
| Total Debt Issued | -- | -- | -97.37% | -97.37% | -69.98% |
| Total Debt Repaid | -- | -- | -33.96% | -38.71% | -126.67% |
| Issuance of Common Stock | -- | -- | 414.06% | 414.06% | 431.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -38.61% | -40.89% | -13.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 1,656.85% | 1,656.85% | 695.98% |